FDA Approved: TOPIRAMATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TOPIRAMATE (Cipla USA Inc.), authorizing changes to the product labeling under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Migraine

Drugs mentioned

• Topiramate (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)